Calcitonin gene-related peptide improves skin flap survival and tissue inflammation

Neuropeptides

Volumn 32, Issue 3, 1998, Pages 269-273

  Gherardini, G ^a,b   Gurlek A ^c   Milner, S M ^d,e   Matarasso, A ^f   Evans, G R D ^c   Jernbeck, J ^a   Lundeberg, T ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UTMB   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE[8-37]; MYELOPEROXIDASE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIA; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN FLAP; SURVIVAL;

EID: 0031859986     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(98)90047-6     Document Type: Article

References (26)

1. Puckett CL, Winters RRW, Geter RK, Goebel D. Studies of pathologic vasoconstriction (vasospasm) in microvascular surgery. J Hand Surg 1985; 10A: 343-349.
2. Johns R A, DiFazio C A, Longnecker D E. Lidocaine constricts or dilatates rat arterioles in a dose-dependent manner. Anesthesiology 1985; 62: 141-144.
3. Granger D N, Kubes P. The microcirculation and inflammation: modulation of leucocyte-endothelial cell adhesion. J Leukoc Biol 1994; 55: 662-675.
4. Wang X, Fiscus RR, Yang L, Mathews HL. Suppression of the functional activity of IL-2-activated lymphocytes by CGRP. Cell Immunol 1995; 162: 105-113.
5. Rees R, Punch J, Shaheen K, Cashmer B, Guice K, Smith S. The stress response in skin: the role of neutrophil products in preconditioning. Plast Reconstr Surg 1993; 92: 110-117
6. Granger D N, Kvietys P R, Perry M A. Leukocyte-endothelial cell adhesion induced by ischemia and reperfusion. Can J Physiol Pharmacol 1993; 71: 67-75.
7. Lee C, Kerrigan CL Neutrophil localization following reperfusion of ischemic skin flaps. Plast Reconstr Surg 1992; 89: 910-915.
8. Lee C, Kerrigan CL, Picard-Ami L A. Cyclophosphamide-induced neutropenia: effect on postischemic skin-flap survival. Plast Reconstr Surg 1992; 89: 1092-1097
9. Törkvist L, Ådén U, Lundeberg T, Raud J. Inhibition of leucotriene-synthesis improves dorsal skin flap survival in the rat. Acta Physiol Scand 1995; 154: 511-512.
10. Gherardini G, Lundeberg T, Gazelius B et al. Calcitonin gene-related peptide increases microcirculation after mechanically induced ischemia in an experimental island flap. Ann Plast Surg 1995; 35: 178-183.
11. Jernbeck J, Dalsgaard C-J. Calcitonin gene-related peptide (CGRP) treatment of flaps with compromised circulation in man. Plast Reconstr Surg 1993; 91: 236-244.
12. Kjartansson J, Lundeberg T, Samuelson U, Dalsgaard C-J, Hedén P. Calcitonin gene-related peptide (CGRP) and transcutaneous electrical nerve stimulation (TENS) increase cutaneous blood flow in the dorsal musculocutaneous flap in the rat. Acta Physiol Scand 1989; 134: 89-94.
13. Hedén P, Jernbeck J, Kjartansson J et al. Increased skin flap survival and arterial dilatation by calcitonin gene-related peptide. A study in the pig. Scand J Plast Reconstr Surg Hand Surg 1989; 23: 11-16.
14. Jernbeck J, Samuelson U. Effects of lidocaine and calcitonin gene-related peptide (CGRP) on isolated human radial arteries. J Reconstr Microsurg 1993; 5: 361-365.
15. Kjartansson J, Dalsgaard C-J, Jonsson C-E. Decreased survival of experimental critical flaps in rats after sensory denervation with capsaicin. Plast Reconstr Surg 1987; 79: 218-221.
16. Kjartansson J, Dalsgaard C-J. Calcitonin gene-related peptide increases survival of a musculocutaneous critical flap in the rat. Eur J Pharmacol 1987; 142: 355-358.
17. Raud J, Lundeberg T, Brodda-Jansen G. Potent anti-inflammatory action of calcitonin gene-related peptide. Biochem Biophys Res Commun 1991; 180: 1429-1435.
18. Samuelson UE, Jernbeck J. Calcitonin gene-related peptide relaxes porcine arteries via one endothelium-dependent and one endothelium-independent mechanism. Acta Physiol Scand 1991; 141: 281-282.
19. Brodda Jansen G. Contributions of calcitonin gene-related peptide in ischemia, inflammation and nociception. PhD thesis, Karolinska Institute, Stockholm, Sweden, 1996.
20. Gherardini G, Evans G R D, Theodorsson E et al. Calcitonin gene-related peptide in experimental ischemia. Implication of an endogenous anti-ischemic effect. Ann Plast Surg 1996; 36: 1-5.
21. Gherardini G, Evans G R D, Milner S M et al. Comparison of vascular effects of calcitonin gene-related peptide and lidocaine on human veins. J Reconstr Microsurg 1995; 11: 179-183.
22. Schierwagen C, Bylund-Fellenius A-C, Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 1990; 23: 179-186.
23. Buckley T L, Brain, S D, Rampart M, Williams T J. Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation. Br J Pharmacol 1991, 103: 1515-1519.
24. Clementi G, Amico-Roxas M, Caruso A et al. Effects of CGRP in different models of mouse ear inflammation. Life Sci 1994; 54: 119-124
25. Umeda Y, Takamiya M, Yoshizaki H, Arisawa M. Inhibition of mitogen-stimulated T lymphocyte proliferation by calcitonin gene-related peptide. Biochem Biophys Res Commun 1988; 154: 227-235.
26. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.